Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use

This study has been completed.

Sponsors and Collaborators:	Alcon Research Ophthalmic Research Associates
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00347984

Purpose

The objective of this study was to evaluate the effect of Systane® compared to marketed artificial tears on the frequency of drop use.

Condition	Intervention
Dry Eye	Drug: Systane Lubricant eye drops

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Crossover Assignment, Safety/Efficacy Study
Official Title:	The Effect of Systane® Compared to Marketed Artificial Tears on Frequency of Drop Use

Further study details as provided by Alcon Research:

Primary Outcome Measures:

Secondary Outcome Measures:

Product questionnaire; Symptoms; Corneal and conjunctival staining; Tear film break-up time (TFBUT).

Estimated Enrollment:	50
Study Start Date:	December 2005
Study Completion Date:	February 2006
Primary Completion Date:	February 2006 (Final data collection date for primary outcome measure)

Eligibility

Criteria

Inclusion Criteria:

Subjects age 18 (minimum); reported history of dry eye syndrome in both eyes; TFBUT ≤ 7 seconds in at least 1 eye at Visit 1; ≥ 1+ fluorescein staining score in any region in at least 1 eye at Visit 1; desire to use an artificial tear substitute for dry eye symptoms at least 4 times per day at Visit 1 and Visit 2.

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00347984

Locations

United States, Massachusetts
Maryland
Andover, Massachusetts, United States, 01845

Sponsors and Collaborators

Alcon Research

Ophthalmic Research Associates

Investigators

Study Director:

Mike Christensen

Alcon Research

More Information

Study ID Numbers:	05-004-09
Study First Received:	June 30, 2006
Last Updated:	August 4, 2008
ClinicalTrials.gov Identifier:	NCT00347984
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Lacerations
Tetrahydrozoline

ClinicalTrials.gov processed this record on January 14, 2009